Greg Appelbaum

315 posts

Greg Appelbaum

Greg Appelbaum

@GregAppelbaum

Applied cognitive neuroscientist studying ways to improve the human condition. Professor at University of California, San Diego. Head @UCSDOptiLab

right here Katılım Ekim 2013
320 Takip Edilen330 Takipçiler
Rolling Stone
Rolling Stone@RollingStone·
Mike Gordon’s mission with XenboX is like a cross between ancient, mythical quest and cutting-edge R&D about understanding the creative process and the concept of flow. In a lot of ways, it started more than 40 years ago, before Phish. The story: rollingstone.com/music/music-fe…
Rolling Stone tweet media
Rolling Stone@RollingStone

.@mike_gordon’s Quest to Understand the Science Behind the ‘Flow State’ You know that feeling you get when you’re really in the zone? The Phish bassist is creating a tool to capture that. Story: rollingstone.com/music/music-fe…

English
4
4
8
28.7K
Athena Stein PhD MPH
Athena Stein PhD MPH@SteinAthena·
Big announcement! 🇺🇸 In two weeks, I will be moving to Chapel Hill, North Carolina to start a postdoc research position working with @FrohlichLab at @NeuroStimCtr I will be conducting clinical trials using at-home, personalised, closed-loop #tACS in #MDD Watch this space! 🧠
Athena Stein PhD MPH tweet media
English
6
0
47
2K
Greg Appelbaum
Greg Appelbaum@GregAppelbaum·
Happy to share this new article done in collaboration with USA Baseball showing that machine learning can account for >50% of the variance hard hit baseballs during competitive games #baseball, #ai, #PDP #https://www.tandfonline.com/doi/full/10.1080/02640414.2024.2363679
English
0
0
1
156
Greg Appelbaum retweetledi
Chuck Lynch
Chuck Lynch@cl9681·
There is a postdoc position available in the Lynch Lab. We are looking for folks interested in how "deeper" characterizations of individual brains could enable new ways of studying mood disorders & help develop personalized brain stimulation interventions. Please RT / share!
Chuck Lynch tweet media
English
1
18
28
7.9K
Greg Appelbaum retweetledi
NEJM
NEJM@NEJM·
Late breaking at #APAAM23: Ketamine versus Electroconvulsive therapy (ECT) for Nonpsychotic Treatment-Resistant Major Depression (ELEKT-D trial) nej.md/3ODZMPc Read the editorial: nej.md/43jyUIR #psychiatry
NEJM tweet media
English
8
136
407
210.8K
Greg Appelbaum
Greg Appelbaum@GregAppelbaum·
Maybe we need a multi site, dose-response study for aiTBS. If 8 hours of treatment works as well or better, then we might have an option that fits in a workday
Noah S Philip MD@NoahSPhilipMD

@GregAppelbaum I agree. we will need to find an option that works within a workday for staff.

English
1
0
5
439
Greg Appelbaum retweetledi
Noah S Philip MD
Noah S Philip MD@NoahSPhilipMD·
@GregAppelbaum I agree. we will need to find an option that works within a workday for staff.
English
0
1
0
578
Greg Appelbaum
Greg Appelbaum@GregAppelbaum·
we are currently running 3 accelerated TMS trials at this moment and by far the most challenging element of these studies is maintaining clinical coverage for 10+ hours a day. Can't wait to read this new article from Noah and his colleagues.
Noah S Philip MD@NoahSPhilipMD

Accelerated TMS is exciting. @SanneRooij, @AArulpragasam TL Bill McDOnald and I put our heads together to ponder opportunities and challenges. 🧵 1/x. In @NPP later this year & ty @CRodriguezMDPhD for the invite. Paper -> rdcu.be/dcNPx @VAProvidence @BrownPsychiatry

English
1
0
10
472
Greg Appelbaum retweetledi
NeuroImage
NeuroImage@NeuroImage_EiC·
that...didn't go how we expected
English
2
24
194
52.3K

Keşfet

@mike_gordon @sciencefriday @RollingStone @brandonsneed @SteinAthena @FrohlichLab @NeuroStimCtr @foxmdphd